The first bit of deception comes in the subtitle, "Right to Try Act." Give the bill a close reading and it will become obvious that no such right is conferred. Ethicist Arthur Caplan says it would be more accurate to call it a "Right to Beg Act." Under the act, patients and their physicians may request access from pharmaceutical or device manufacturers, but manufacturers or investigators are under no obligation to grant such access. If manufacturers or investigators do grant access, they may also "require an eligible patient to pay the costs of … the manufacture of the investigational drug, biological product or device." These costs could be quite high, effectively eliminating the poor from access.